CN3737775
Expired
Amendment A3
Supply of Advate and Adynovate Imported Plasma and Recombinant Products
$109.5M
Contract Value
Contract Details
- Contract ID
- CN3737775
- Status
- active
- Financial Year
- FY25
- Category
- Drugs and Pharmaceutical(UNSPSC: 51000000)
Key Dates
- Publish Date
- 5 July 2024
- Signed Date
- 17 Dec 2020
- Start Date
- 31 Dec 2019
- End Date
- 29 June 2025
- Duration
- 5 years, 7 months
Procurement Information
- Procurement Method
- Limited tender
- Exemption Code
- BP
- Exemption Reason
- App A: 11. Blood plasma products or plasma fractionation services.
Contract History
This contract has been amended 3 times. Currently showing amendment A3.
Original Contract
Published 17 Dec 2020 · 31 Dec 2019 to 29 June 2025
$85.5M
Amendment A1
Published 5 July 2024 · 31 Dec 2019 to 29 June 2025
$52.5M
$-33000000
Amendment A2
Published 5 July 2024 · 31 Dec 2019 to 29 June 2025
$87.6M
+$35.1M
Amendment A3
Current
Published 5 July 2024 · 31 Dec 2019 to 29 June 2025
$109.5M
+$21.9M
Supplier
TAKEDA PHARMACEUTICALS AUSTRALIA PTY. LTD.
- ABN
- 71 095 610 870
- Entity Type
- Australian Private Company
- Location
- NSW